Esophageal cancer: Recent advances in screening, targeted therapy, and management
- PMID: 25395880
- PMCID: PMC4229783
- DOI: 10.4103/1477-3163.143720
Esophageal cancer: Recent advances in screening, targeted therapy, and management
Abstract
The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor marker for surveillance purposes, ways to target esophageal cancer stem cells as well as circulating tumor cells, and developing minimally invasive protocols to treat early-stage disease. The goal of this chapter is to highlight some of the recent advances and ongoing research in the field of esophageal cancer.
Keywords: Barrett's; cancer stem cells; carcinogenesis/tumorigenesis; dysplasia; esophageal cancer; targeted therapy.
Conflict of interest statement
References
-
- American Cancer Society. Cancer Facts and Figures 2014. Atlanta GACS. 2014. [Last accessed on 2014 Aug 02]. Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/... .
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin. 2012;62:283–98. - PubMed
-
- Peters FP, Curvers WL, Rosmolen WD, de Vries CE, Ten Kate FJ, Krishnadath KK, et al. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: Nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus. 2008;21:475–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
